FDA recall D-0712-2022
Athenex Pharma Solutions, LLC · Class II · drug
Product
Epinephrine Injection 8 mg per 250 mL in 0.9% Sodium Chloride, 8mg, 250 mL excel bag, Rx only, Athenex Pharma Solutions, LLC, Clarence, NY, 14031, NDC 76154-814-15
Reason for recall
Defective container
Distribution
USA nationwide.
Key facts
- Status
- Terminated
- Initiation date
- 2022-03-14
- Report date
- 2022-03-30
- Termination date
- 2022-08-04
- Voluntary/Mandated
- Voluntary: Firm initiated
- Location
- Clarence, NY, United States
Primary source
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0712-2022